MPXA-2000
K222036Medipixel, Inc. · cleared 2023-03-22 · product code QIH · Radiology
Premarket evidence — what FDA accepted
source quote (p.5)
“MPXA-2000, the stand-alone application, is cardiovascular image analysis software for the viewing and quantification of X-ray angiographic images of the coronary arteries.”
source quote (p.5)
“MPXA-2000 is developed based on Deep-learning (Classification and Segmentation of vessels) and Computer vision algorithms (Measurements of vessels) to analyze the images and provide quantification of the vessels in real-time.”
source quote (p.8)
“The Deep-learning algorithm used in MPXA-2000 was validated by the standalone performance test (Doc. No. TD-XA2-SPTR) using the method of comparing the analysis results obtained from MPXA-2000 with the ground truth annotated by experienced experts.”
source quote (p.9)
“A cybersecurity verification testing was conducted to demonstrate the integrity, confidentiality, and availability of MPXA-2000 through testing for identified vulnerabilities of product.”
Validation studies (1)
Retrospective clinical
n=305 images
endpoints: vessel segmentation assessment; vessel classification assessment; ROI analysis assessment
standards: IEC 62304 Edition 1.1 2015-06 Medical device software - Software life cycle processes, General Principles of Software Validation (Jan 11, 2002), Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices: Guidance for Industry and FDA Staff (Nov 05, 2005), Content of Premarket Submissions for Management of Cybersecurity in Medical Devices, (Oct 2, 2014)
Reported performance (2 observations)
source quote (p.8)
“The vessel classification accuracy: 0.9934”
source quote (p.8)
“The vessel segmentation Dice similarity Coefficient (DSC): 0.9200(Pass criteria of > 0.8)”
Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.
Predicate network
Postmarket — what happened after clearance
Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.
Reimbursement — how devices like this got paid
Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).